This brand name is authorized in Estonia, Croatia
The drug AXHIDROX contains one active pharmaceutical ingredient (API):
|
1
Glycopyrronium
UNII A14FB57V1D - GLYCOPYRRONIUM
|
|
Glycopyrronium is an inhaled long-acting muscarinic receptor antagonist (anticholinergic) for once-daily maintenance bronchodilator treatment of COPD. Glycopyrronium works by blocking the bronchoconstrictor action of acetylcholine on airway smooth muscle cells, thereby dilating the airways. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| D11AA01 | D Dermatologicals → D11 Other dermatological preparations → D11A Other dermatological preparations → D11AA Antihidrotics | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1841598 |
| Country: HR | Agencija za lijekove i medicinske proizvode | Identifier(s): HR-H-407852925 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
